MCM2 and pulmonary arterial hypertension: In agreement with these data, expression levels of mini chromosome maintenance protein 2 (MCM2) and polo-like kinase 1 (PLK1) (two cell proliferative markers) and Survivin (an anti-apoptosis factor) were dose-dependently diminished in TFP-treated PAH-PASMCs (Figure 1B).